| Anita Louise Licata, MD | |
|
354 Mountain View Dr, Suite 300, Colchester, VT 05446-5988 | |
| (802) 864-0192 | |
| (802) 860-4919 |
| Full Name | Anita Louise Licata |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 35 Years |
| Location | 354 Mountain View Dr, Colchester, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356444509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 042-0008753 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Four Seasons Dermatology Llc | 8820062946 | 11 |
| Four Seasons Dermatology Llc | 8820062946 | 11 |
News Archive
Tomorrow, the Food and Drug Administration (FDA) will hold a hearing to consider approval of a new drug application for an abortifacient drug, ulipristal acetate, as an emergency contraceptive, or a new "Plan B."
By examining expression of every human gene in clear cell renal cell carcinoma compared to normal kidney cells, researchers at Mayo Clinic's campus in Florida have discovered gene signatures they say explain much of the biology of this common and difficult-to-treat kidney cancer.
Researchers at the ARC Centre of Excellence for Nanoscale BioPhotonics, led by the University of Adelaide, have successfully developed an advanced new imaging technique, which can help assess the quality of early-stage embryos.
Pfizer Inc. announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.
Researchers at the Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine (TUSM) have uncovered a mechanism that may help explain the severe forms of schistosomiasis, or snail fever, which is caused by schistosome worms and is one of the most prevalent parasitic diseases in the world. The study in mice, published online in The Journal of Immunology, may also offer targets for intervention and amelioration of the disease.
› Verified 8 days ago
| Entity Name | Four Seasons Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790737393 PECOS PAC ID: 8820062946 Enrollment ID: O20040824001173 |
News Archive
Tomorrow, the Food and Drug Administration (FDA) will hold a hearing to consider approval of a new drug application for an abortifacient drug, ulipristal acetate, as an emergency contraceptive, or a new "Plan B."
By examining expression of every human gene in clear cell renal cell carcinoma compared to normal kidney cells, researchers at Mayo Clinic's campus in Florida have discovered gene signatures they say explain much of the biology of this common and difficult-to-treat kidney cancer.
Researchers at the ARC Centre of Excellence for Nanoscale BioPhotonics, led by the University of Adelaide, have successfully developed an advanced new imaging technique, which can help assess the quality of early-stage embryos.
Pfizer Inc. announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.
Researchers at the Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine (TUSM) have uncovered a mechanism that may help explain the severe forms of schistosomiasis, or snail fever, which is caused by schistosome worms and is one of the most prevalent parasitic diseases in the world. The study in mice, published online in The Journal of Immunology, may also offer targets for intervention and amelioration of the disease.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anita Louise Licata, MD 354 Mountain View Drive, Suite 300, Colchester, VT 05446-5988 Ph: (802) 658-8624 | Anita Louise Licata, MD 354 Mountain View Dr, Suite 300, Colchester, VT 05446-5988 Ph: (802) 864-0192 |
News Archive
Tomorrow, the Food and Drug Administration (FDA) will hold a hearing to consider approval of a new drug application for an abortifacient drug, ulipristal acetate, as an emergency contraceptive, or a new "Plan B."
By examining expression of every human gene in clear cell renal cell carcinoma compared to normal kidney cells, researchers at Mayo Clinic's campus in Florida have discovered gene signatures they say explain much of the biology of this common and difficult-to-treat kidney cancer.
Researchers at the ARC Centre of Excellence for Nanoscale BioPhotonics, led by the University of Adelaide, have successfully developed an advanced new imaging technique, which can help assess the quality of early-stage embryos.
Pfizer Inc. announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred to as skin scarring.
Researchers at the Sackler School of Graduate Biomedical Sciences at Tufts and Tufts University School of Medicine (TUSM) have uncovered a mechanism that may help explain the severe forms of schistosomiasis, or snail fever, which is caused by schistosome worms and is one of the most prevalent parasitic diseases in the world. The study in mice, published online in The Journal of Immunology, may also offer targets for intervention and amelioration of the disease.
› Verified 8 days ago
Ms. Mary B Harkin, N.P. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 354 Mountain View Dr, Suite 300, Colchester, VT 05446 Phone: 802-864-0192 Fax: 802-860-4919 | |
Dr. Glenn David Goldman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 354 Mountain View Dr Ste 300, Colchester, VT 05446 Phone: 802-864-0192 Fax: 802-860-4919 |